Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
09:32am, Thursday, 04'th Sep 2025
New Service Empowers Clinicians with Personalized Insights from Coriell Life Sciences to Optimize Prescribing Across Specialties SECAUCUS, N.J. , Sept. 4, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 03'rd Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Majority of fentanyl positives also contain other drugs, with co-positivity with marijuana doubling since 2020 SECAUCUS, N.J. , Sept. 2, 2025 /PRNewswire/ -- The percentage of employees in the general
Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy?
10:50am, Thursday, 28'th Aug 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
DGX Stock Gains Following a New Joint Venture With Corewell Health
09:50am, Thursday, 28'th Aug 2025
Quest Diagnostics shares rise after forming a joint venture with Corewell Health to expand advanced lab services across Michigan.
Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan
09:00am, Tuesday, 26'th Aug 2025
Parties to build state-of-the-art laboratory in Southfield to serve physicians and patients across the state Quest will also manage Corewell Health's 21 hospital labs SOUTHFIELD, Mich. and GRAND RAPI
FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
08:52am, Monday, 25'th Aug 2025
SECAUCUS, N.J. , Aug. 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA)
Why Is Quest Diagnostics (DGX) Up 8.2% Since Last Earnings Report?
12:31pm, Thursday, 21'st Aug 2025
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
11:16am, Thursday, 21'st Aug 2025
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
Eleventh Circuit Upholds Dismissal Of Qui Tam FCA Suit For Failure To Meet Rule 9(b) Specificity
10:15am, Tuesday, 19'th Aug 2025
OverviewIn a qui tam action filed under the False Claims Act, the relator, Barbara Senters, appealed the district court's dismissal of her fourth amended complaint (FAC), which alleged that Quest Diag
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
06:14pm, Friday, 15'th Aug 2025
SECAUCUS, N.J. , Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will spea
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
10:45am, Thursday, 14'th Aug 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Quest Diagnostics Declares Quarterly Cash Dividend
06:35pm, Wednesday, 13'th Aug 2025
SECAUCUS, N.J. , Aug. 13, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash divide
Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types
09:08am, Thursday, 07'th Aug 2025
SECAUCUS, N.J. and BOSTON , Aug. 7, 2025 /PRNewswire/ -- Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, today announced a research collaboration with Mass General Brigham investigators a
Quest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care
08:33am, Tuesday, 05'th Aug 2025
SECAUCUS, N.J. , Aug. 5, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its previously announced acquisit
